NDC 0469-5020 – Myrbetriq
Mirabegron 8 mg/mL · Granule, For Suspension, Extended Release · Oral
Product NDC0469-5020
Product details
- Brand name
- Myrbetriq
- Generic name
- Mirabegron
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- Granule, For Suspension, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA213801
- Marketed since
- March 25, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- beta3-Adrenergic Agonist
Active ingredients
- Mirabegron 8 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0469-5020-99 | 1 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE | Mar 25, 2021 |